Abiopharma

Clinical trial NCT05099172: completion date: 2029-06-29 → 2031-06-30.

Clinical trial NCT06717308 updates: 1. completion date: 2026-09-15 → 2027-03-31 2. primary completion date: 2026-08-31 → 2027-02-28

Clinical trial NCT05929235: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05492110 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-03-06 → 2026-08-05 3. primary completion date: 2026-03-06 → 2026-08-04 4. enrollment type: ESTIMATED → ACTUAL 5. masking: TRIPLE → QUADRUPLE 6. collaborators added: East Kent Hospitals University NHS Foundation Trust

Clinical trial NCT07347379 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-09-01 3. enrollment: 500 → 108 participants

Clinical trial NCT06565156 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-30 3. primary completion date: 2026-04-01 → 2025-11-14

Clinical trial NCT05776927 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-08-04

Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30

Clinical trial NCT05308901 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-06-01 → 2025-08-11

Clinical trial NCT06198712 updates: 1. collaborators added: Novo Nordisk A/S. This study is currently undergoing a sponsor transition from Forma Therapeutics, Inc. to Novo Nordisk A/S. 2. collaborators removed: Novo Nordisk A/S